<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing, multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> characterized predominantly by recurrent orogenital <z:mpath ids='MPATH_579'>ulcers</z:mpath>, skin involvement, and <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recurrent mucocutaneous lesions may be the only symptom in mild cases, but ocular, gastrointestinal, and central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement may occur in severe cases </plain></SENT>
<SENT sid="2" pm="."><plain>We report in this study the successful treatment with infliximab of severe life-threatening GI <z:mp ids='MP_0001914'>bleeding</z:mp> caused by an ileal <z:mpath ids='MPATH_579'>ulcer</z:mpath> in a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="3" pm="."><plain>Antitumor <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) therapy could be an emergency therapeutic option in patients with massively <z:mp ids='MP_0001914'>bleeding</z:mp> <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and unstable patients or those with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001914'>bleeding</z:mp> with other TNF-alpha-mediated <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Another option for anti-TNF therapy could be as bridging management between conservative and surgical treatment </plain></SENT>
</text></document>